Chemical Structure : CGI-1746
CAS No.: 910232-84-7
Catalog No.: PC-42817Not For Human Use, Lab Use Only.
CGI-1746 is a potent, highly selective, second-generation BTK inhibitor with IC50 of 1.9 nM, displays 1,000-fold selectivity over Tec and Src family kinases.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $248 | In stock | |
100 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CGI-1746 is a potent, highly selective, second-generation BTK inhibitor with IC50 of 1.9 nM, displays 1,000-fold selectivity over Tec and Src family kinases.
CGI-1746 displays no significant binding affinity for other 385 kinases.
CGI-1746 abolishes FcγRIII-induced TNFα, IL-1β and IL-6 production in macrophages, blocks B cell receptor-dependent B cell proliferation and in prophylactic regimens reduces autoantibody levels in collagen-induced arthritis.
CGI-1746 inhibits myeloma-like tumors both in vitro and in vivo.
M.Wt | 579.6887 | |
Formula | C34H37N5O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzamide, N-[3-[4,5-dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)- |
1. Di Paolo JA, et al. Nat Chem Biol. 2011 Jan;7(1):41-50.
2. Young WB, et al. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1333-7.
3. Yang Y, et al. Cancer Res. 2015 Feb 1;75(3):594-604.
4. Kokabee L, et al. Cancer Biol Ther. 2015;16(11):1604-15.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright